You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The integration on the Microsoft Azure cloud is helping Kaiser make its vast genomics dataset available to a wider pool of researchers.
The precision medicine center at Colorado's UCHealth expects to add 100,000 participants annually and have 17 drug-gene pairs for pharmacogenomics this year.
Italy's Dante Labs is building one of Europe's largest genomic labs and leading an effort to sequence 100,000 whole genomes around the Mediterranean.
IQvia, the lead investor in this round, will work with BC Platforms to integrate genomic and clinical data in a secure environment to support biomedical research.
Germany's Life & Brain Genomics hopes to streamline sample management and genetic array input for its multi-omics analysis services.
The companies will combine clinical genetic testing services with data management technology to support precision medicine for rare diseases.
The partnership with Finnish medical data sciences services vendor MedEngine will help BC Platforms offer end-to-end services for pharma and health-tech companies.
Finnish medical evidence provider Medaffcon will tap BC Platforms' global biobank analysis platform to generate medical evidence for researchers.
Nashville Biosciences will offer access to BioVU, Vanderbilt University Medical Center's collection of DNA samples and patient records, through BC Platforms' solution.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.